Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management
- PMID: 25399715
- PMCID: PMC4280814
- DOI: 10.1111/irv.12293
Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management
Abstract
This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.
Keywords: Antivirals; clinical management; immunocompromised; influenza; respiratory; treatment.
© 2014 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
Similar articles
-
Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.Antiviral Res. 2016 May;129:21-38. doi: 10.1016/j.antiviral.2016.01.012. Epub 2016 Feb 9. Antiviral Res. 2016. PMID: 26872862 Free PMC article.
-
18th International Conference on Antiviral Research. Respiratory viruses.IDrugs. 2005 Jun;8(6):465-6. IDrugs. 2005. PMID: 15906188 No abstract available.
-
Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.Antiviral Res. 2019 Jul;167:45-67. doi: 10.1016/j.antiviral.2019.04.006. Epub 2019 Apr 8. Antiviral Res. 2019. PMID: 30974127 Free PMC article. Review.
-
Therapeutic potential of resveratrol against emerging respiratory viral infections.Pharmacol Ther. 2020 Oct;214:107613. doi: 10.1016/j.pharmthera.2020.107613. Epub 2020 Jun 17. Pharmacol Ther. 2020. PMID: 32562826 Review.
-
Antiviral therapy for respiratory viral infections in immunocompromised patients.Expert Rev Anti Infect Ther. 2017 Apr;15(4):401-415. doi: 10.1080/14787210.2017.1279970. Epub 2017 Jan 16. Expert Rev Anti Infect Ther. 2017. PMID: 28067078 Free PMC article. Review.
Cited by
-
Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.Sci Rep. 2018 Jun 25;8(1):9633. doi: 10.1038/s41598-018-27890-4. Sci Rep. 2018. PMID: 29941893 Free PMC article.
-
A clinical approach to the threat of emerging influenza viruses in the Asia-Pacific region.Respirology. 2017 Oct;22(7):1300-1312. doi: 10.1111/resp.13114. Epub 2017 Jul 5. Respirology. 2017. PMID: 28677861 Free PMC article. Review.
-
Epidemiology and outcomes of hospitalized adults with respiratory syncytial virus: A 6-year retrospective study.Influenza Other Respir Viruses. 2019 Jul;13(4):331-338. doi: 10.1111/irv.12643. Epub 2019 Apr 11. Influenza Other Respir Viruses. 2019. PMID: 30977284 Free PMC article.
-
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus.Eur J Med Chem. 2017 Jul 28;135:467-478. doi: 10.1016/j.ejmech.2017.04.070. Epub 2017 Apr 27. Eur J Med Chem. 2017. PMID: 28477572 Free PMC article.
-
Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications.Vaccine. 2016 Oct 26;34(45):5442-5448. doi: 10.1016/j.vaccine.2016.08.057. Epub 2016 Sep 9. Vaccine. 2016. PMID: 27622299 Free PMC article. Review.
References
-
- Programme of the third isirv-Antiviral Group Conference, June 4–6, 2014, Tokyo, Japan. Available at: http://www.isirv.org/site/images/stories/avg/documents/intranet/Tokyo/pr... (Accessed 1 September 2014). Website 2014.
-
- CDC. Influenza Risk Assessment Tool (IRAT). Available at: http://www.cdc.gov/flu/pandemic-resources/tools/risk-assessment.htm (Accessed 1 September 2014). Website 2014.
-
- WHO. Overview of the emergence and characteristics of the avian influenza A(H7N9) virus. Available at: http://www.who.int/influenza/human_animal_interface/influenza_h7n9/WHO_H... (Accessed 1 September 2014). Website 2013.
-
- WHO. Confirmed human cases of avian influenza A(H7N9) reported to WHO. Available at: http://www.who.int/influenza/human_animal_interface/influenza_h7n9/17_Re... (Accessed 1 September 2014). Website 2014.
-
- Gao HN, Lu HZ, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013;368:2277–2285. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical